The 51st Annual Meeting of the European Society for Blood and Marrow Transplantation: Pharmacist Committee – Oral Session (O167-O168)

• November 5, 2025

Paediatric traumatic brain injury: unique population and unique challenges

• by Shruti Agrawal, Rebekah Mannix, Vicki Anderson, Miriam H Beauchamp, Adam Ferguson, Lucia W Braga, Shu-Ling Chong, Anthony Figaji, Christopher Giza, David K Menon, Michael J Bell

• December 13, 2025

HIV-1 Drug Resistance in Children and Implications for Pediatric Treatment Strategies: A Systematic Review and Meta-analysis

• by Joseph Fokam, Aude Christelle Ka’e, Bouba Yagai, Maria Mercedes Santoro, Judith Kose Otieno, Natella Rakhmanina, Collins Ambe Chenwi, Alex Durand Nka, Ezechiel Ngoufack Jagni Semengue, Davy-Hyacinthe Gouissi, Willy Leroi Pabo Togna, Nelly Kamgaing, Tetang Suzie, Desire Takou, Georges Teto, Tatiana Tekoh, Jeremiah Efakika Gabisa, Audrey Nayang Mundo, Lum Forgwei, Naomi-Karell Etame, Aurelie Minelle Kengni Ngueko, Michel Carlos Tommo Tchouaket, Boris Tchounga, Patrice Tchendjou, Joelle Nounouce Bouba Pamen, Rogers Ajeh Awoh, Gregory-Edie Halle-Ekane, Giulia Cappelli, Alexis Ndjolo, Francesca Ceccherini-Silberstein, Vittorio Colizzi, Jean Kaseya, Nicaise Ndembi, Carlo Federico Perno

• June 26, 2025

New Phase 3 Clinical Trial Opens for Pediatric, Adult Hodgkin Lymphoma Patients

While an estimated 95% of “younger” patients diagnosed with Hodgkin lymphoma are still alive and into survivorship within five years of their diagnosis, their long-term health suffers from the aggressive treatment needed to fight the disease.

• November 10, 2025

• 2 min